Clinical Trials Browser

Phase 3 × Completed × Leukemia, Promyelocytic, Acute × Clear all

Leukemia, Promyelocytic, Acute

NCT00482833 2022-10-12

APL0406

Phase 3 Completed

276 enrolled

Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

NCT00006223 2013-06-24

flt3L in Treating Patients With Acute Myeloid Leukemia

Phase 3 Completed

Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

NCT00003934 2013-06-05

Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia

Phase 3 Completed

420 enrolled

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00599937 2008-01-24

APL93: Timing of CxT and Role of Maintenance

Phase 3 Completed

576 enrolled

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Clinical Trials

TUD-APOLLO-064

APL0406

flt3L in Treating Patients With Acute Myeloid Leukemia

Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia

APL93: Timing of CxT and Role of Maintenance